Orthofix and SeaSpine Complete Merger

Orthofix Medical and SeaSpine announced the successful completion of their previously announced merger.

Under merger terms, a wholly-owned subsidiary of Orthofix will merge with and into SeaSpine, with SeaSpine continuing as the surviving company and a wholly-owned subsidiary of Orthofix. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade on NASDAQ under the symbol OFIX. The combined company will be renamed at a later date, and until then will continue to be known as Orthofix Medical Inc.

The combined Orthofix is a global spine and orthopedics company with a complementary portfolio of biologics, spinal hardware solutions, bone growth therapies, specialized orthopedic solutions and a surgical navigation system.

“The completion of this merger catalyzes our ambition to be an industry leader in spine and orthopedics,” said Keith Valentine, President and CEO of Orthofix effective as of the closing. “I’m privileged to lead this talented team and excited for all of the opportunities that lie ahead. Together we are stronger and better positioned to deliver innovative, quality-driven solutions for surgeons in their work to improve patients’ lives.”

In addition to Mr. Valentine, previously announced members of the combined company’s executive leadership team include:

  • John Bostjancic, Chief Financial Officer
  • Roberto Donadello, Senior Vice President, Global Operations
  • Kim Elting, President, Global Orthopedics
  • Ehab Esmail, Senior Vice President, Global Quality, Regulatory and Clinical Affairs
  • Kevin Kenny, President, Global Spine
  • Tyler Lipschultz, President, Global Biologics
  • Beau Standish, President, Global Enabling Technologies

The company is headquartered in Lewisville, Texas, and has primary offices in Carlsbad, California, with a focus on spinal product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine and Sunnyvale, California; Toronto, Canada; Wayne, Pennsylvania; Olive Branch, Mississippi; Maidenhead, UK; Munich, Germany; Paris, France and Sao Paulo, Brazil.

Source: Orthofix Medical

JAV

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE